Varenicline BID

ApprovedSmall molecule

Pfizer

Varenicline BID is one of 30 small molecule programs targeting Smoking Cessation. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Smoking CessationActive, not recruiting

Smoking CessationApproved

Active, not recruiting

Competition

Competitive Landscape

154 competitors in Smoking Cessation

#DrugCompanyPhaseTrials

Wellbutrin

GSK

Phase 3

5 2

Chantix

Pfizer

Phase 3

3 3

Ozempic

Novo Nordisk

Phase 3

2 4

Topamax

WWim Janssens

Phase 3

3 5

Rimonabant

Sanofi

Phase 3

5 6

Lopid

Pfizer

Phase 2

1 7

Pharmacotherapy

UUniversity of Pittsburgh

Phase 3

1 8

Standard Treatment

Boehringer Ingelheim

Phase 3

1 9

Zocor

OOrganon and Co

Phase 2

1 10

Selincro

IIndivior Inc.

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2028

Post-ApprovalRecruiting

Smoking Cessation

NCT06798324

Q4 2030

Phase 2Recruiting

Trial

NCT07040566

Clinical

Trials by Indication[1]

Smoking Cessation2 trials

Smoking Cessation Study In Healthy Adolescent Smokers

Completed· Pfizer logo

Pfizer·Phase 4·NCT01312909·312 enrolled

tDCS Plus Varenicline for Smoking Cessation

Recruiting·CCentre for Addiction and Mental Health·Phase 4·NCT06798324·160 enrolled

Trial1 trial

A Trial of Varenicline for E-cigarette Cessation

Recruiting·YYale University·Phase 2·NCT07040566·326 enrolled

Tobacco Use Disorder1 trial

A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV

Completed·YYale University·Phase 4·NCT04490057·323 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Varenicline BID. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Varenicline BID compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Varenicline BID. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Pfizer

Varenicline BID

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2028

Q4 2030

Trials by Indication[1]

Smoking Cessation2 trials

Trial1 trial

Tobacco Use Disorder1 trial

References

Drug Info

Quick Facts

Related News